Current report filing

Document And Entity Information

Document And Entity Information
Mar. 16, 2023
Cover [Abstract]  
Document Type 8-K/A
Amendment Flag true
Document Period End Date Mar. 16, 2023
Entity Registrant Name JANONE INC.
Entity Central Index Key 0000862861
Amendment Description On March 15, 2023, JanOne Inc. (the “Company”) announced that it had entered into an agreement to dispose of three of its subsidiaries. The following day (March 16, 2023), the Company and the prospective purchaser of the subsidiaries determined that certain fundamental transaction issues in respect of the announced disposition remained open and that, therefore, the Company could not have consummated the transactions contemplated by the agreement, which agreement, at that time, also did not bind the Company. Nevertheless, the Company retains its expectation that it will become a “pure biopharma” enterprise. In that regard, the Company has undertaken a series of steps in anticipation of effectuating such a potential disposition, the economic terms of which the Company anticipates may be as or more favorable than the terms of the unenforceable transaction.
Entity Emerging Growth Company false
Entity File Number 000-19621
Entity Incorporation, State or Country Code NV
Entity Tax Identification Number 41-1454591
Entity Address, Address Line One 325 E. Warm Springs Road, Suite 102
Entity Address, City or Town Las Vegas
Entity Address, State or Province NV
Entity Address, Postal Zip Code 89119
City Area Code 702
Local Phone Number 997-5968
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.001 par value per share
Trading Symbol JAN
Security Exchange Name NASDAQ